自身免疫性内分泌疾病中的Th1趋化因子
本文综述了CXC趋化因子受体CXCR3及其趋化因子CXCL10、CXCL9和CXCL11在自身免疫性甲状腺炎、Graves病、甲状腺眼病、1型糖尿病和Addison病中的作用。甲状腺滤泡细胞、眶后细胞、β细胞和胰岛细胞及肾上腺细胞响应干扰素-γ刺激产生大量此类趋化因子,循环水平升高并与疾病早期阶段及活动期、严重程度相关。许多研究提示CXCR3及其趋化因子可能作为这些疾病新药治疗的潜在靶点。
要点
- 甲状腺滤泡细胞、眶后细胞、β细胞和胰岛细胞及肾上腺细胞在干扰素-γ刺激下产生大量CXCR3趋化因子。
- 在自身免疫性甲状腺炎、Graves病、甲状腺眼病、1型糖尿病和Addison病中,循环趋化因子水平升高并与早期自身免疫反应相关。
- 高水平的趋化因子还与Graves病和甲状腺眼病的活动期、甲状腺功能减退或亢进的严重程度及暴发性1型糖尿病相关。
核心结论
- 综述数据表明Th1免疫反应在不同自身免疫性内分泌疾病中具有重要性,许多研究提示CXCR3及其趋化因子可能被视为治疗这些疾病的新药潜在靶点。
研究设计与样本
- 通过PubMed检索文献,检索上述趋化因子与自身免疫性甲状腺炎、Graves病、甲状腺眼病、1型糖尿病和Addison病的组合。
主要发现
- 自身免疫性甲状腺炎和Graves病的甲状腺滤泡细胞、甲状腺眼病的眶后细胞(成纤维细胞、前脂肪细胞、成肌细胞)、1型糖尿病的β细胞和胰岛以及Addison病的肾上腺细胞响应干扰素-γ刺激产生大量这些趋化因子。
- 淋巴细胞和外周血单核细胞部分负责分泌Th1趋化因子。
- 在自身免疫性甲状腺炎、Graves病、甲状腺眼病、1型糖尿病和Addison病中,这些趋化因子的循环水平升高,并与所有上述疾病的自身免疫反应早期阶段相关。
- 高水平的这些趋化因子还与Graves病和甲状腺眼病的活动期相关,其他研究显示与Addison病甲状腺功能减退的严重程度、Graves病甲状腺功能亢进的严重程度、甲状腺眼病的严重程度或暴发性1型糖尿病相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The CXC chemokine receptor CXCR3 and its chemokines CXCL10, CXCL9, and CXCL11 are implicated in the pathogenesis of autoimmune diseases. Here, we review these chemokines in autoimmune thyroiditis (AT), Graves disease (GD), thyroid eye disease (TED), type 1 diabetes (T1D), and Addison's disease (AAD). EVIDENCE ACQUISITION: A PubMed review of the literature was conducted, searching for the above-mentioned chemokines in combination with AT, GD, TED, T1D, and AAD. EVIDENCE SYNTHESIS: Thyroid follicular cells in AT and GD, retroorbital cells in TED (fibroblasts, preadipocytes, myoblasts), β cells and islets in T1D, and adrenal cells in AAD respond to interferon-γ (IFN-γ) stimulation producing large amounts of these chemokines. Furthermore, lymphocytes and peripheral blood mononuclear cells (PBMC) are in part responsible for the secreted Th1 chemokines. In AT, GD, TED, T1D, and AAD, the circulating levels of these chemokines have been shown to be high. Furthermore, these chemokines have been associated with the early phases of the autoimmune response in all the above-mentioned disorders. High levels of these chemokines have been associated also with the "active phase" of the disease in GD, and also in TED. Other studies have shown an association with the severity of hypothyroidism in AD, of hyperthyroidism in GD, with severity of TED, or with fulminant T1D. CONCLUSION: The reviewed data have shown the importance of the Th1 immune response in different endocrine autoimmune diseases, and many studies have suggested that CXCR3 and its chemokines might be considered as potential targets of new drugs for the treatment of these disorders.
引用
- Fallahi P, Ferrari SM, Ragusa F, et al. Th1 Chemokines in Autoimmune Endocrine Disorders. J Clin Endocrinol Metab. 2020. PMID: 31863667. doi:10.1210/clinem/dgz289
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。